Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$274.66 USD
-8.42 (-2.97%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $274.50 -0.16 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
A Value F Growth F Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Elevance Health, Inc. has a PEG ratio of 0.94 compared to the Medical Services industry's PEG ratio of 1.52.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ELV 274.66 -8.42(-2.97%)
Will ELV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ELV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELV
Cigna to Report Q2 Earnings: Can Evernorth Offset Healthcare Weakness?
Can Humana Beat Q2 Earnings Estimates on Insurance Unit Strength?
ELV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can Optum Support UnitedHealth's Profit Amid Industry Headwinds?
Medical Expenses Erode Centene's Bottom Line in Rare Q2 Earnings Miss
Company News for Jul 18, 2025
Other News for ELV
Thermo Fisher Scientific Inc Sees Significant Reduction in Eaton Vance Worldwide Health ...
UnitedHealth sets 2025 outlook below consensus amid rising medical costs
UnitedHealth stumbles on weak profit outlook, drags peers lower
UnitedHealth stumbles as annual profit outlook disappoints
UnitedHealth Stock Is A Strong Buy Amid Unfavorable Medical Trends (Upgrade)